Core Laboratories NV Net Income
| CLB Stock | USD 17.40 0.12 0.68% |
As of the 27th of February, Core Laboratories shows the Risk Adjusted Performance of 0.1225, downside deviation of 2.15, and Mean Deviation of 1.8. Core Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Core Laboratories Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.8175 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 31.8 M | 30.2 M | |
| Net Income Applicable To Common Shares | 31.8 M | 30.2 M | |
| Net Income From Continuing Ops | 28.9 M | 27.5 M | |
| Net Income Per Share | 0.68 | 1.20 | |
| Net Income Per E B T | 0.69 | 0.54 |
Core | Net Income | Build AI portfolio with Core Stock |
Analyzing Core Laboratories's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Core Laboratories's current valuation and future prospects.
Latest Core Laboratories' Net Income Growth Pattern
Below is the plot of the Net Income of Core Laboratories NV over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Core Laboratories financial statement analysis. It represents the amount of money remaining after all of Core Laboratories NV operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Core Laboratories' Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Core Laboratories' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 31.8 M | 10 Years Trend |
|
Net Income |
| Timeline |
Core Net Income Regression Statistics
| Arithmetic Mean | 83,544,756 | |
| Coefficient Of Variation | 113.11 | |
| Mean Deviation | 72,542,643 | |
| Median | 63,895,000 | |
| Standard Deviation | 94,497,277 | |
| Sample Variance | 8929.7T | |
| Range | 355.1M | |
| R-Value | (0.59) | |
| Mean Square Error | 6153.5T | |
| R-Squared | 0.35 | |
| Significance | 0.01 | |
| Slope | (11,133,491) | |
| Total Sum of Squares | 142875.8T |
Core Net Income History
Other Fundumenentals of Core Laboratories
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Core Laboratories Net Income component correlations
Core Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Core Laboratories is extremely important. It helps to project a fair market value of Core Stock properly, considering its historical fundamentals such as Net Income. Since Core Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Core Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Core Laboratories' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. Projected growth potential of Core fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Core Laboratories assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.03) | Dividend Share 0.04 | Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth 0.07 |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Core Laboratories' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Core Laboratories should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Core Laboratories' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Core Laboratories 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Core Laboratories' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Core Laboratories.
| 11/29/2025 |
| 02/27/2026 |
If you would invest 0.00 in Core Laboratories on November 29, 2025 and sell it all today you would earn a total of 0.00 from holding Core Laboratories NV or generate 0.0% return on investment in Core Laboratories over 90 days. Core Laboratories is related to or competes with Crossamerica Partners, Borr Drilling, Precision Drilling, Granite Ridge, Nabors Industries, Vitesse Energy, and MorningStar Partners. Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and ga... More
Core Laboratories Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Core Laboratories' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Core Laboratories NV upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.15 | |||
| Information Ratio | 0.102 | |||
| Maximum Drawdown | 11.7 | |||
| Value At Risk | (4.17) | |||
| Potential Upside | 5.51 |
Core Laboratories Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Core Laboratories' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Core Laboratories' standard deviation. In reality, there are many statistical measures that can use Core Laboratories historical prices to predict the future Core Laboratories' volatility.| Risk Adjusted Performance | 0.1225 | |||
| Jensen Alpha | 0.2131 | |||
| Total Risk Alpha | 9.0E-4 | |||
| Sortino Ratio | 0.1163 | |||
| Treynor Ratio | 0.2723 |
Core Laboratories February 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1225 | |||
| Market Risk Adjusted Performance | 0.2823 | |||
| Mean Deviation | 1.8 | |||
| Semi Deviation | 1.86 | |||
| Downside Deviation | 2.15 | |||
| Coefficient Of Variation | 658.76 | |||
| Standard Deviation | 2.45 | |||
| Variance | 6.02 | |||
| Information Ratio | 0.102 | |||
| Jensen Alpha | 0.2131 | |||
| Total Risk Alpha | 9.0E-4 | |||
| Sortino Ratio | 0.1163 | |||
| Treynor Ratio | 0.2723 | |||
| Maximum Drawdown | 11.7 | |||
| Value At Risk | (4.17) | |||
| Potential Upside | 5.51 | |||
| Downside Variance | 4.63 | |||
| Semi Variance | 3.46 | |||
| Expected Short fall | (2.05) | |||
| Skewness | 0.3861 | |||
| Kurtosis | 0.6898 |
Core Laboratories Backtested Returns
Core Laboratories appears to be not too volatile, given 3 months investment horizon. Core Laboratories secures Sharpe Ratio (or Efficiency) of 0.0962, which signifies that the company had a 0.0962 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Core Laboratories NV, which you can use to evaluate the volatility of the firm. Please makes use of Core Laboratories' Risk Adjusted Performance of 0.1225, mean deviation of 1.8, and Downside Deviation of 2.15 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Core Laboratories holds a performance score of 7. The firm shows a Beta (market volatility) of 1.33, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Core Laboratories will likely underperform. Please check Core Laboratories' value at risk, expected short fall, and the relationship between the treynor ratio and downside variance , to make a quick decision on whether Core Laboratories' price patterns will revert.
Auto-correlation | -0.65 |
Very good reverse predictability
Core Laboratories NV has very good reverse predictability. Overlapping area represents the amount of predictability between Core Laboratories time series from 29th of November 2025 to 13th of January 2026 and 13th of January 2026 to 27th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Core Laboratories price movement. The serial correlation of -0.65 indicates that roughly 65.0% of current Core Laboratories price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.65 | |
| Spearman Rank Test | -0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 0.36 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Core Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Core Laboratories NV reported net income of 31.8 M. This is 98.6% lower than that of the Energy Equipment & Services sector and 32.16% lower than that of the Energy industry. The net income for all United States stocks is 94.43% higher than that of the company.
Core Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Core Laboratories' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Core Laboratories could also be used in its relative valuation, which is a method of valuing Core Laboratories by comparing valuation metrics of similar companies.Core Laboratories is currently under evaluation in net income category among its peers.
Core Laboratories ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Core Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Core Laboratories' managers, analysts, and investors.Environmental | Governance | Social |
Core Laboratories Institutional Holders
Institutional Holdings refers to the ownership stake in Core Laboratories that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Core Laboratories' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Core Laboratories' value.| Shares | Northern Trust Corp | 2025-06-30 | 608.4 K | Gendell Jeffrey L | 2025-06-30 | 569.5 K | Fred Alger Management, Llc | 2025-06-30 | 544.4 K | Charles Schwab Investment Management Inc | 2025-06-30 | 541 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 481.5 K | Hotchkis & Wiley Capital Management Llc | 2025-06-30 | 457.9 K | Bank Of New York Mellon Corp | 2025-06-30 | 405.5 K | Van Eck Associates Corporation | 2025-06-30 | 349.6 K | Ubs Group Ag | 2025-06-30 | 342.9 K | Ariel Investments, Llc | 2025-06-30 | 13 M | Blackrock Inc | 2025-06-30 | 7.3 M |
Core Fundamentals
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0595 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 956.96 M | ||||
| Shares Outstanding | 46.56 M | ||||
| Shares Owned By Insiders | 2.00 % | ||||
| Shares Owned By Institutions | 98.00 % | ||||
| Number Of Shares Shorted | 4.24 M | ||||
| Price To Earning | 101.74 X | ||||
| Price To Book | 2.92 X | ||||
| Price To Sales | 1.56 X | ||||
| Revenue | 526.52 M | ||||
| Gross Profit | 108.93 M | ||||
| EBITDA | 63.5 M | ||||
| Net Income | 31.8 M | ||||
| Cash And Equivalents | 22.85 M | ||||
| Cash Per Share | 0.29 X | ||||
| Total Debt | 206.33 M | ||||
| Debt To Equity | 1.29 % | ||||
| Current Ratio | 2.23 X | ||||
| Book Value Per Share | 5.99 X | ||||
| Cash Flow From Operations | 37.18 M | ||||
| Short Ratio | 12.37 X | ||||
| Earnings Per Share | 0.68 X | ||||
| Price To Earnings To Growth | 1.67 X | ||||
| Target Price | 15.83 | ||||
| Number Of Employees | 3.3 K | ||||
| Beta | 1.09 | ||||
| Market Capitalization | 821.58 M | ||||
| Total Asset | 596.95 M | ||||
| Retained Earnings | 150.28 M | ||||
| Working Capital | 129.02 M | ||||
| Current Asset | 238.55 M | ||||
| Current Liabilities | 120.76 M | ||||
| Annual Yield | 0 % | ||||
| Five Year Return | 2.66 % | ||||
| Net Asset | 596.95 M | ||||
| Last Dividend Paid | 0.04 |
About Core Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Core Laboratories NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core Laboratories NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:Check out You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. Projected growth potential of Core fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Core Laboratories assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.03) | Dividend Share 0.04 | Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth 0.07 |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Core Laboratories' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Core Laboratories should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Core Laboratories' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.